Loading…
Influx Healthtech (INFLUX)₹253.00−1.94%Pharmaceuticals
Influx Healthtech is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 28.5 against a peer median of 28.5, and ROCE of 40.1% against a peer median of 13.5%, and latest-quarter sales growth of 40.3% against a peer median of 31.2%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Amanta Healthcare | 784 | 54.2 | 12.0 | 10.4 | 1.12 | 0.0 | 289 | 15 | 5.3 | −5.7 | vs INFLUX |
| Shree Ganesh Remedies | 779 | 50.4 | 14.0 | 10.9 | 0.19 | 0.0 | 109 | 18 | −41.8 | −67.3 | vs INFLUX |
| Zim Laboratories | 735 | 180.1 | 5.0 | 1.6 | 0.43 | 0.0 | 374 | 6 | 31.4 | — | vs INFLUX |
| Kilitch Drugs (India) | 701 | 23.2 | 13.1 | 10.5 | 0.32 | 0.0 | 235 | 30 | 4.0 | −13.6 | vs INFLUX |
| Wanbury | 700 | 10.4 | 31.1 | 68.4 | 1.56 | 0.0 | 648 | 66 | −4.1 | 10.0 | vs INFLUX |
| Valiant Laboratories | 605 | 37.7 | 1.0 | −1.2 | 0.15 | 0.0 | 237 | −3 | 145.0 | 945.3 | vs INFLUX |
| Influx Healthtech | 587 | 28.5 | 40.1 | 30.0 | 0.00 | 0.0 | 147 | 21 | 40.3 | 37.4 | — |
| Transchem | 509 | 119.3 | — | — | 0.00 | 0.0 | 0 | 4 | — | 204.5 | vs INFLUX |
| Trident Lifeline | 505 | 22.3 | 21.0 | 22.6 | 0.73 | 0.1 | 129 | 19 | 50.4 | 29.5 | vs INFLUX |
| KRM Ayurveda | 495 | 24.5 | 35.0 | 29.0 | 0.00 | 0.0 | 102 | 20 | 31.0 | 123.8 | vs INFLUX |
| Albert David | 457 | 20.2 | 1.0 | −0.4 | 0.08 | 0.6 | 333 | −1 | 42.3 | 300.6 | vs INFLUX |
| Peer median | 605 | 28.5 | 13.5 | 10.7 | 0.19 | 0.0 | 235 | 18 | 31.2 | 33.5 |
Listed companies closest to Influx Healthtech in Pharmaceuticals include Amanta Healthcare, Shree Ganesh Remedies, Zim Laboratories, Kilitch Drugs (India), Wanbury, Valiant Laboratories, Transchem, Trident Lifeline.
Amanta Healthcare, with a market cap of ₹784 Cr.
Influx Healthtech trades at a P/E of 28.5; the median of its peer set is 28.5. A P/E above or below the median is a description, not a judgement on value.
Influx Healthtech's return on capital employed is 40.1%, above the peer median of 13.5%.